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Abstract
Background The development of Barrett’s esophagus is poorly understood, but it has been suggested that cardiac mucosa is a
precursor of intestinal type metaplasia and that inflammation of cardiac mucosa may play a role in the formation of Barrett’s
esophagus. The present study was undertaken to examine the presence and distribution of immune-inflammatory cells in
cardiac mucosa, specifically focusing on dendritic cells because of their importance as regulators of immune reactions.
Material and Methods Endoscopic biopsy specimens were obtained from 12 patients with cardiac mucosa without Barrett’s
esophagus or adenocarcinoma and from 21 patients with Barrett’s esophagus without dysplasia (intestinal metaplasia).
According to histology, in nine of the 21 specimens with Barrett’s esophagus, areas of mucosa composed of cardiac type
epithelium-lined glands were present as well. Immunohistochemical staining and electron microscopy were used to examine
immune-inflammatory cells in paraffin-embedded sections.
Results Immune-inflammatory cells, including T cells, B cells, dendritic cells, macrophages, and mast cells, were present in
the connective tissue matrix that surrounded cardiac type epithelium-lined glands in all patients with cardiac mucosa.
Clustering of dendritic cells with each other and with lymphocytes and the intrusion of dendritic cells between glandular
mucus cells were observed. In the Barrett’s esophagus specimens that contained cardiac type glands, computerized CD83
expression quantitation revealed that there were more dendritic cells in cardiac mucosa than in intestinal metaplasia.
Conclusion Immune-inflammatory infiltrates containing dendritic cells are consistently present in cardiac mucosa. The
finding of a larger number of dendritic cells in areas of cardiac mucosa in Barrett’s esophagus biopsies suggests that
the immune inflammation of cardiac mucosa might play a role in modifying the local tissue environment to promote the
development of specialized intestinal type metaplasia.
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Introduction
Cardiac mucosa is a type of mucosa that is lined by simple
mucinous columnar epithelium with no parietal cells or
chief cells, and this distinguishes cardiac mucosa from
gastric oxyntic mucosa.1–3 In the past, it was believed that
up to 2 cm of cardiac mucosa was normally present in the
most proximal section of the stomach where it separates the
parietal and chief cell-containing gastric oxyntic mucosa
from the esophageal mucosa lined by squamous-stratified
epithelium (squamous mucosa).1–4 This prevailing view
was challenged by studies suggesting that cardiac mucosa,
rather than being a normally occurring mucosa, might be an
acquired, metaplastic epithelium that develops in response
to exposure of esophageal squamous epithelium to gastric
acid.2 According to this hypothesis, at the normal gastro-
esophageal junction, squamous mucosa transitions directly
with oxyntic mucosa of the gastric fundus with no
interposed segment of cardiac mucosa.2 An examination
of the gastroesophageal junction in a large number of
autopsies of subjects, the medical records of whom had no
mention of gastroesophageal reflux disease, has revealed
that, in most children and adults younger than 20 years of
age, the squamous mucosa of the distal esophagus
transitioned directly with the oxyntic mucosa of the gastric
fundus with no interposed segment of cardiac type simple
columnar epithelium.5 Further observations suggested that
the development of cardiac mucosa is induced by exposing
squamous epithelium to refluxed gastric acid.2,6–8 This
introduced the possibility that the formation of cardiac
mucosa may be the first step in the development of
Barrett’s esophagus,1,2,5,6 although controversy regarding
the nature and etiology of cardiac mucosa remains.
Unfortunately, limitations as to the accurate location of
endoscopic biopsies1,3,6 and the rapid autolysis of the mucosa
of the gastroesophageal junction in autopsy specimens1,5
have made it difficult to resolve this controversy.
It is thought that the primary importance of cardiac
mucosa is that it represents the only mucosal type that can
progress to specialized intestinal type metaplasia.1,2 Once
intestinalized, the esophagus seems to acquire an increased
ability to withstand damage by refluxed gastric juice,
compared with cardiac mucosa.1,2 However, the develop-
ment of specialized intestinal type of metaplasia (Barrett’s
esophagus) can also be a detrimental change because
specialized intestinal type epithelium is capable of
further progression to epithelial dysplasia and adenocar-
cinoma.1–8 Available evidence suggests that cardiac
mucosa itself is benign and that it is only with the
development of intestinal type metaplasia the mucosa
becomes premalignant.1,2
It is established that premalignant conditions develop in
the presence of chronic inflammation and that immune
mechanisms are critically involved in the development of
cancer in these precancerous tissues.9–11 A variety of
inflammatory and immune cells populate the Barrett’s
esophagus mucosa, including T and B lymphocytes, mast
cells, and macrophages.12–14 We recently reported that
antigen-presenting dendritic cells are present in Barrett’s
esophagus with a significant increase in their spatial density in
adenocarcinoma compared to benign Barrett’s esophagus.14
Dendritic cells are powerful initiators and regulators of
immune reactions15–19 and thus may have a role in the
pathogenesis of Barrett’s esophagus and adenocarcinoma.14
In contrast to Barrett’s esophagus, cardiac mucosa has
received only very limited attention, possibly because it is not
associated with an increased risk of cancer.1,2 Nevertheless, it
has been noted that inflammatory cells are so routinely
present in cardiac mucosa biopsies that an alternative term
for cardiac mucosa is “carditis.”1,3 The inflammation is not
related to either Helicobacter pylori infection or other gastric
mucosal pathology.2 This prominent inflammatory infiltrate
led to the suggestion that it may play a role in the formation
of Barrett’s esophagus, but there have been no detailed
studies in this area.2,4 We undertook this study to examine
the immune-inflammatory cells, especially the presence,
distribution, and cell interactions of dendritic cells, in cardiac
mucosa.
Material and Methods
Tissue Specimens and Routine Histology
Endoscopic biopsy specimens selected for the present study
were obtained from 12 patients without Barrett’s esophagus
or adenocarcinoma and from 21 patients with Barrett’s
esophagus without dysplasia. The specimens were taken
from the tubular esophagus above the proximal extent of
the gastric rugal folds from varying areas of the columnar-
lined segment. The length of the columnar-lined esophagus
varied from approximately 1 cm to approximately 4 cm.
Tissue specimens were defined as Barrett’s esophagus when
specialized intestinal type columnar epithelium containing
true goblet cells (specialized intestinal metaplasia) was
present in any length of the columnar-lined esophagus.
Cardiac mucosa was diagnosed by the presence of
columnar epithelium consisting of mucous cells without
any specialized cells such as parietal, chief, or goblet cells.
Histological examination demonstrated that amongst 21
biopsy specimens with Barrett’s esophagus, cardiac type
glands were also present in nine specimens, while no
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gastric (oxyntic) type epithelium was detected in any
specimen. Only intestinal metaplasia was present in the
other 12 specimens. Tissue specimens were processed by
standard formalin fixation and paraffin embedding.
Material was collected in accordance with the principles
outlined in the Declaration of Helsinki and informed,
written consent was obtained from each patient. The study
was approved by the Institutional Review Board of St.
Vincent’s Hospital, Sydney and the University of New
South Wales, Sydney.
Single and Double Immunostaining Procedures
and Quantitative Analysis
Dendritic cells were identified using anti-CD83 (Immunotech;
cat. no. IM-2069; 1:50 dilution) and anti-DC-SIGN (Santa
Cruz; cat. no. sc-65892; 1:50 dilution). CD83, an inducible
glycoprotein belonging to the immunoglobulin superfamily, is
important in T cell immunity mediated by dendritic cells.20–24
CD83 is the most specific dendritic cell marker expressed by
maturing and mature dendritic cells.21–24 DC-SIGN is
dendritic cell-specific intercellular molecule-3 (ICAM-3)-
grabbing nonintegrin.25,26 T cells were identified using anti-
CD3 (Dako; cat. no. A0452; 1:100 dilution); B cells were
identified with anti-CD20 (Beckman-Coulter; cat. no. 1925;
1:50 dilution); macrophages were identified with anti-CD68
(Dako; cat. no. M0876; 1:50 dilution); mast cells were
identified with antimast cell tryptase (Abcam; cat. no. ab
2378; 1:50 dilution).
For single immunostaining, after elimination of endoge-
nous peroxidase activity by 3% H2O2, sections were
preincubated with normal nonimmune serum and then tested
by avidin–biotin complex (ABC) using a standard ABC
immunoperoxidase method. Briefly, after washing in Tris-
phosphate buffered saline (TPBS), pH 7.6, the sections were
incubated with a biotin-labeled secondary antibody, followed
by a treatment with ABC (ELITE ABC, VECTOR
PK61000). After washing in TPBS, brown staining was
produced by 5 min treatment with 3,3′-diaminobenzidine
(DAB). All the incubations were completed at room
temperature. Archival lymph node sections were used for
positive controls. For negative controls, the first antibodies
were omitted or the sections were treated with an immuno-
globulin fraction of nonimmune serum as a substitute for the
primary antibody. None of the negative control sections
showed positive immune staining. Counterstaining was
performed with Mayer’s hematoxylin.
A computerized quantitative analysis of CD83 expression
was carried out at ×400 magnification using the Image-Pro
Plus image analysis program (Media Cybernetics, Bethesda,
MD, USA). CD83 expression was measured in each section in
at least seven randomly selected microscopic fields containing
both CD83+ cells and epithelial glands. Statistical compar-
ison of expression, measured in pixels per standard
microscopic field (0.04 mm2), was performed by t test using
Prism® 5 (GraphPad Software, San Diego, CA, USA).
Double immunostaining with CD83/CD3 and CD83/
CD20 was used to analyze the possible colocalization of
dendritic cells with lymphocytes, using previously reported
methods.14,27 In brief, after visualization of CD83 with the
ABC substrate kit, sections were washed with 0.1 M
glycine–hydrochloric acid buffer, pH 2.2, and then incu-
bated with anti-CD3 or anti-CD20 antibody. After rinsing
in TPBS, the sections were incubated with biotinylated
secondary antibody and then with alkaline phosphatase-
conjugated streptavidin (Dako) or with ABC (Dako). A
combination of the peroxidase–antiperoxidase (PAP) and
alkaline phosphatase–antialkaline phosphatase (APAAP)
techniques with antigen visualization with DAB or Fast
Red was also used. Controls were the same as for single
immunostaining. Counterstaining was performed with
Mayer’s hematoxylin.
Figure 1 Dendritic cells and T cells in cardiac mucosa in esophageal
biopsy specimens showing different degrees of inflammation (a, b). In
a and b, CD83 antigen was visualized using ABC immunoperoxidase
reaction (brown reaction product) while CD3+ cells were visualized
using a Fast Red substrate kit (rose reaction product). Counterstaining
with Mayer’s hematoxylin. Bars=50 μm (a, b).
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Electron Microscopy
Fresh endoscopic biopsy specimens were fixed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer
(pH 7.4), routinely processed and embedded in Spurr
resin. Ultrathin sections were stained with uranyl acetate
and lead citrate and examined with the aid of a Morgagni
268D electron microscope. The electron microscopic
identification of dendritic cells was carried out according
to their distinctive ultrastructural features which include
the tubulovesicular system and atypical granules as
previously used.14,28
Figure 2 Direct contacts between dendritic cells and lymphocytes in
cardiac mucosa (a–g). CD83 antigen was visualized using ABC
immunoperoxidase reaction (brown reaction product) (a–g) while
CD3+ T cells (b, c) and CD20+ B cells (d–g) were visualized using a
Fast Red substrate kit (rose reaction product). Counterstaining with
Mayer’s hematoxylin. e is a detail of d. g Dendritic cells contacting
each other. Bars=25 μm (a–c, e–g) and 50 μm (d).
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Results
Tissue specimens in which metaplastic intestinal type
columnar epithelium was not present contained only cardiac
type columnar epithelium consisting of mucous cells. No
parietal or chief cells were detected in any of these
specimens, and thus, these tissue specimens were identified
as cardiac mucosa. According to routine hematoxylin and
eosin histology, all 12 cardiac mucosa specimens contained
inflammatory cells in the connective matrix surrounding the
glands. Immunohistochemistry revealed that immune-
inflammatory infiltrates consisted of T cells (CD3+), B
cells (CD20+), macrophages (CD68+), and mast cells (mast
cell tryptase+).
The use of dendritic cell-specific markers, including
CD83 and DC-SIGN, demonstrated the presence of
dendritic cells in all tissue specimens where they repre-
sented a minor cell population (Fig. 1a,b). The degrees of
immune inflammation varied markedly between the speci-
mens. Figure 1a,b shows representative images of double-
immunostained cardiac mucosa specimens in which a
difference in the intensity of immune inflammation is
readily identifiable. Despite that the intensity of immune
inflammation varied markedly in all specimens examined,
individually located dendritic cells (Fig. 2a) as well as
dendritic cells contacting T cells were observed in the
connective matrix of the cardiac mucosa (Fig. 2b,c). In all
specimens, dendritic cells clustering with B cells (Fig. 2d–f)
Figure 3 Electron micrographs
showing dendritic cells and their
direct contacts with lymphocytes
in cardiac mucosa (a–e). In a, d,
and e, dendritic cells are marked
by large stars while dendritic
cell processes are marked by
smaller stars (a–d). Arrows in
a–d show the tubulovesicular
system which is markedly
hypertrophied in the cellular
processes (b, c). d A close
apposition between a dendritic
cell and a lymphocyte-like cell
(asterisk). e A contact between a
dendritic cell and a plasma cell
(asterisk). In d, note hypertrophy
of atypical granules in the den-
dritic cell. Bars=2 μm (a), 1 μm
(b, c), 5 μm (d), and 3 μm (e).
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as well as dendritic cells contacting each other (Fig. 2g)
were also observed.
Immunohistochemical findings were confirmed by the
identification of dendritic cells and their direct contacts
with lymphocytes in the cardiac mucosa by electron
microscopy (Fig. 3a–e). Cells with the unique ultrastruc-
tural features of the dendritic cell family, including the
tubulovesicular system and atypical granules,16,28,29 were
seen in ultrathin sections (Fig. 3a–e). Through cell
processes or by direct apposition of cell bodies, dendritic
cells formed contacts with lymphocytes (Fig. 3d,e).
Cisterns of the tubulovesicular system were usually
hypertrophied in dendritic cell processes (Fig. 3a–c) while
the hypertrophy of atypical granules occurred predominantly
in the perinuclear cytoplasm of dendritic cells (Fig. 3d).
In cardiac mucosa, dendritic cells were found not only in
the connective tissue matrix but also along the basal
membrane of epithelial cells as well as, in some glands,
between mucous cells (Fig. 4a–e). The intensity of the
expression of CD83 notably varied between dendritic cells
located along the glandular basal membrane (Fig. 4a–e). In
the glands, which contained dendritic cells incorporated
between mucous cells, the focal accumulations of T cells
were also observed (Fig. 4a–e). In these foci, the clustering
of dendritic cells with T cells occurred along the basal
membrane (Fig. 4a–e).
Apart from being located in the connective matrix or
being associated with the glands, dendritic cells were
regularly observed around and within capillaries and
microvessels, forming a network in cardiac mucosa. In this
location, dendritic cells typically displayed high levels of
CD83 expression.
The present study aimed to not only examine the features
and patterns of distribution of dendritic cells in cardiac
mucosa but also to compare the spatial density of dendritic
cells located in the tissue matrix containing cardiac type
epithelium-lined glands with the spatial density of dendritic
cells located in the tissue matrix containing specialized
Figure 4 Intrusion of dendritic
cells and T cells between mucous
cells in cardiac mucosa (a–e).
Note contacts between dendritic
cells and T cells along the
affected basal membrane, under-
lying mucous cells (a–e). Note
also various intensities of the
expression of CD83 antigen by
dendritic cells located along the
basal membrane of the glandular
epithelial cells (a–e). In a–e,
CD83 antigen was visualized
using ABC immunoperoxidase
reaction (brown reaction product)
while CD3+ cells were visualized
using a Fast Red substrate kit
(rose reaction product). Counter-
staining with Mayer’s
hematoxylin. Bars=25 μm (a–e).
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intestinal type epithelium-lined glands in tissue specimens
of Barrett’s esophagus which contained areas with cardiac
mucosa. A semiquantitative analysis indicated that, in these
specimens, the numbers of dendritic cells in the connective
tissue matrix surrounding cardiac type epithelium-lined
glands were greater than the numbers of dendritic cells in
the connective tissue matrix that surrounded intestinal type
epithelium-lined glands. This was verified by a computerized
quantitative analysis of CD83 expression, which found an
approximately twofold higher expression of CD83 in cardiac
mucosa tissue matrix, compared with that in the Barrett’s
esophagus connective tissue matrix (959±254 vs 616±
172 pixels per standard field; Fig. 5a–c). The distribution
patterns of dendritic cells around specialized intestinal type
epithelium-lined glands in tissue specimens of Barrett’s
esophagus corresponded to those described by us earlier.14
Discussion
In agreement with previous notes,2–4 this study showed that
cardiac mucosa contains an immune-inflammatory cell infil-
trate. Immune inflammation was present in all cardiac mucosa
tissues examined in the present study, although the degree of
inflammatory cell infiltration varied considerably between
cardiac mucosa specimens. The immune-inflammatory infil-
trates were consistently enriched by dendritic cells, which
were present not only around glands in cardiac mucosa but
also focally penetrated between glandular mucous cells,
suggesting that the integrity of the epithelium in these foci
was disrupted. Dendritic cells often formed contacts with both
T cells and B cells in areas of the affected glandular basal
membrane as well as in the connective tissue matrix adjacent
to the glands. This could indicate that the activation of some
lymphocytes might occur in situ within the mucosa, although
the classic pathway for the migration of antigen-loaded
dendritic cells through the vascular system to lymphoid organs
cannot be excluded, especially as dendritic cells intensely
expressing CD83 antigen were observed around and within
capillaries and microvessels.
The intensity of the expression of CD83, a marker of
dendritic cell maturation,21–24 varied between the cells in
cardiac mucosa, but dendritic cells that were in contact with
lymphocytes typically displayed high levels of CD83
expression. Supporting the possibility that some dendritic
cells were activated cells, electron microscopy revealed a
marked hypertrophy of atypical granules and cisterns of the
tubulovesicular system, both of which are known to
represent structures involved in antigen-presenting func-
tions of dendritic cells.16,17
An intriguing and potentially important finding of this
study was that focal aggregations of dendritic cells and
dendritic cells contacting each other were identified in the
tissue matrix of cardiac mucosa. Clustering of dendritic
cells with each other is known to occur in a number of
autoimmune diseases16,17,30 and has not been described in
any disease in which autoimmune mechanisms are not
involved. We, therefore, speculate that the immune inflam-
Figure 5 Dendritic cells in
Barrett’s esophagus tissue speci-
mens containing both cardiac type
epithelium (a, c) and specialized
intestinal type epithelium (b, c).
a and b Single ABC immunos-
taining of tissue slides showing
the presence of dendritic cells
(brown) in the lamina propria
surrounding two different types
of glands. Counterstaining with
Mayer’s hematoxylin. Bars=
100 μm (a, b). c Expression of
CD83 antigen in cardiac mucosa
(CM) and in specialized intestinal
type mucosa of Barrett’s esopha-
gus (BE), evaluated as the num-
ber of pixels per standard field
using a computerized quantita-
tive analysis (see the “Material
and Methods” section).
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mation observed in cardiac mucosa might represent an
ongoing autoimmune reaction or that autoimmune mecha-
nisms are at least involved. The finding of dendritic cells
penetrating into glands and closely apposed to glandular
mucous cells also supports this possibility. Further studies
are needed to evaluate the possible role of recruitment of
autoimmune mechanisms in the formation of both cardiac
type metaplasia and Barrett’s esophagus.
Perhaps surprisingly, there were more dendritic cells in the
connective tissue matrix surrounding cardiac type epithelium-
lined glands compared to intestinal type epithelium-lined
glands in the specimens which contained both cardiac mucosa
and Barrett’s intestinal metaplasia. This was confirmed by
measuring the expression of CD83 antigen by dendritic cells,
which was significantly higher in cardiac mucosa compared to
intestinal metaplasia.
Overall, this study’s findings suggest that the individual’s
immune response to ongoing exposure to noxious luminal
contents may have a role in both the development of cardiac
mucosa and its replacement by Barrett’s esophagus. The
importance of cardiac mucosa as the possible precursor
lesion to Barrett’s esophagus is indicated by studies
showing similar protein expression profiles for both
cardiac mucosa and Barrett’s esophagus, including the
expression of the small intestine marker proteins sucrase–
isomaltase and crypt cell antigen, and DAS-1, a marker of
specialized columnar mucosa.31–34 Compelling evidence
has also been provided by studies that found cardiac
mucosa developing in the cervical remnant esophagus after
esophagectomy, an in vivo human model for de novo reflux
disease.3,35 In one such study,35 intestinal metaplasia
developed in some patients with adenocarcinoma subsequently
arising in one protein expression features. The specific cellular
and molecular mechanistic events that induce change from
cardiac mucosa to Barrett’s esophagus are unknown1–8,35–37
but the reduced inflammation in intestinalized mucosa
compared to cardiac mucosa, shown in the present study,
supports the teleological argument that intestinal metaplasia
develops to protect the esophagus against the inflammation
induced by injurious components of the refluxate.2 The role
of immune mechanisms, and possibly autoimmune mecha-
nisms, in the neglected cardiac mucosa and in the formation
of Barrett’s esophagus requires further evaluation.
The present study is the first to report the presence of
dendritic cells in cardiac mucosa. There is an ever-increasing
body of data on the use of dendritic cells in immune
therapeutic approaches against cancers and autoimmune
diseases.38–41 The finding of dendritic cells in cardiac type
metaplasia might have a practical implication.
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